Ligand Pharmaceuticals Incorporated

NasdaqGM:LGND Stock Report

Mkt Cap: US$1.2b

Ligand Pharmaceuticals Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Todd Davis (61 yo)





Mr. Todd C. Davis serves as an Independent Director of Chromocell Corporation since January 2023 and its Chairman of the Board. He is Chief Executive Officer at Ligand Pharmaceuticals Incorporated since De...

Leadership Team

Todd Davis
CEO & Director0.083yrUS$327.81k0.31%
$ 3.6m
Matthew Korenberg
President & COO0.17yrUS$6.73m0.55%
$ 6.5m
Octavio Espinoza
Chief Financial Officer0.17yrno data0.0049%
$ 57.9k
Simon Latimer
Head of Investor Relationsno datano datano data
Andrew Reardon
Chief Legal Officer0.17yrno data0.065%
$ 769.0k
Todd Pettingill
Director of Corporate Developmentno datano datano data
Audrey Warfield-Graham
Chief People Officer16yrsno datano data
Keith Marschke
Senior Vice President of Biology & Scientific Affairs5yrsno datano data
Vincent Antle
Senior Vice President of Technical Operations & QA - Capitsol5yrsno datano data
Patrick Lucy
Senior VP & CBO Protein Expression Businessno datano datano data


Average Tenure


Average Age

Experienced Management: LGND's management team is not considered experienced ( 0.2 years average tenure), which suggests a new team.

Board Members

Todd Davis
CEO & Director15.83yrsUS$327.81k0.31%
$ 3.6m
John Kozarich
Independent Chairman19.83yrsUS$347.81k0.25%
$ 3.0m
John LaMattina
Independent Director11.92yrsUS$319.81k0.16%
$ 1.9m
Stephen Sabba
Independent Director14.42yrsUS$332.81k0.15%
$ 1.8m
Jason Aryeh
Independent Director16.33yrsUS$322.81k0.44%
$ 5.3m
Shalendar Bhasin
Scientific Advisorno datano datano data
Jason Haas
Director0.58yrno data0.010%
$ 123.0k
Nancy Gray
Independent Director5.42yrsUS$327.81k0.028%
$ 330.8k


Average Tenure


Average Age

Experienced Board: LGND's board of directors are seasoned and experienced ( 14.4 years average tenure).